Biggest News Aggregation in the World
📰 Alligator Bioscience News

Alligator Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alligator Bioscience. Real-time updates on events, politics, business and more.

Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO

OPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration of response (median 12.5 months) and overall survival (median 14.3 months) support continued development of mitazalimab in a randomized confir...
United States Hall On Peter Ellmark Jean Luc Van Laethem Frank Hoerning Andersen Sumeet Ambarkhane

Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting

Alligator Bioscience AB announced that two clinical abstracts on its lead drug candidate mitazalimab, a best- in-class CD40 agonist, in first line metastatic pancreatic cancer will be presented in a...
United States American Society Of Clinical Oncology Alligator Bioscience Clinical Oncology Annual Meeting Objective Response Rate

Immuno-Oncology Clinical Trials Market Size & Share to Surpass $18.1 Billion by 2030

WASHINGTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Immuno-Oncology Clinical Trials Market has been steadily growing over the years due to increasing incidence of cancer, advancements in cancer research, the growing demand for personalized medicine, increased research and development activities in the field of immuno-oncology, as well as advancements in technology and supportive regulatory frameworks. According to Vantage Market Research, the global Immuno-O
United States Eric Kunz Facebook Youtube Coherus Biosciences Asia Pacific Access To Free Sample Research
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Strong team behind the new SmiLe company Uptake Bio

 SmiLe IncubatorView in browser Strong team behind the new SmiLe company Uptake BioPress release2023-06-28 11:05Anki Malmborg Hager, CEO of Uptake Bio Lund Sweden – Uptake Bio is developing revolutionary radioimmunotherapy drugs that have the ability to target radiotherapy to specific cancer cel...
Ulrika Ringdahl David Ulmert Carl Borrebaeck Malmborg Hager Anders Abrahamsson Bioinvent International

First-line Mitazalimab Plus Chemo Continues to Generate Responses in Metastatic PDAC

Frontline treatment with the combination of the CD40-directed monoclonal antibody agonist mitazalimab and modified FOLFIRINOX continued to produce responses in patients with metastatic pancreatic ductal adenocarcinoma.
Bruxelles Capitale Jean Luc Van Laethem Erasmus University Hospital Alligator Bioscience Gastrointestinal Cancer Metastatic Pancreatic Ductal Adenocarcinoma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science